Apimeds Pharmaceuticals US Inc APUS

$2.27 -0.09 (-3.81%)

Valuation

Market cap: 3,561,000
Revenue TTM: $0
Net income TTM: $-6,000,000
P/E (trailing): 0.00
P/E (forward): —
Profit margin: 0.00%
Debt to equity: 0.08

Trading

Volume: 33,226
Avg volume: 4,747,988
Day's range: $2.20 – $2.37
Shares out: 1,509,000
Stochastic %K: 9%
Beta: 0.13
Analysts: —
Price target: —

Price

Company profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 848 201 5010
Website: https://www.mindwavedao.com
Address: 100 Matawan Rd, Suite 325, Matawan, United States

Latest news

Nov 9, 2026, 8:00 AM EST · 3 days ago

MindWave Innovations Inc. USA and Skalup Capital Singapore Form Bermuda Insurance Joint Venture, Pursue Insurance License with Bermuda Monetary Authority

Nov 3, 2026, 8:00 AM EST · 9 days ago

IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.

Oct 13, 2026, 9:43 AM EDT · 4 weeks ago

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

Sep 29, 2026, 8:30 AM EDT · 6 weeks ago

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

2026-09-24T16:39:21.000Z · 7 weeks ago

Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?

Sep 24, 2026, 8:30 AM EDT · 7 weeks ago

MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits

Sep 18, 2026, 2:00 PM EDT · 7 weeks ago

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Aug 3, 2026, 9:00 AM EDT · 3 months ago

NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange

2026-07-30T13:55:40.000Z · 3 months ago

Apimeds Pharmaceuticals US Inc trading resumes

2026-07-30T13:50:28.000Z · 3 months ago

Apimeds Pharmaceuticals US Inc trading halted, volatility trading pause

Jul 28, 2026, 8:30 AM EDT · 3 months ago

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

Jun 8, 2026, 9:00 AM EDT · 5 months ago

For Second Straight Year, American Public University System (APUS) Earns Great Place to Work® Certification

APEI

May 5, 2026, 2:07 PM EDT · 6 months ago

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

2026-03-25T11:21:47.000Z · 7 months ago

Inscobee, Apimeds Korea deliver action by written consent to remove directors

2026-03-24T12:35:14.000Z · 7 months ago

Apimeds Pharma US reports material breach of merger agreement by Inscobee

Mar 24, 2026, 8:30 AM EDT · 7 months ago

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

2026-02-11T21:55:14.000Z · 9 months ago

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

Feb 11, 2026, 4:51 PM EST · 9 months ago

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Dec 10, 2025, 9:58 AM EST · 11 months ago

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

2025-12-01T14:50:10.000Z · 11 months ago

Apimeds Pharmaceuticals US Inc trading resumes

2025-12-01T14:35:27.000Z · 11 months ago

Apimeds Pharmaceuticals, MindWave Innovations announce merger

Dec 1, 2025, 9:25 AM EST · 11 months ago

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

2025-12-01T14:05:31.000Z · 11 months ago

Apimeds Pharmaceuticals US Inc trading halted, news pending

Nov 10, 2025, 10:00 AM EST · 1 year ago

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

2025-10-14T09:30:18.000Z · 1 year ago

Apimeds Pharmaceuticals expands AI Futures Lab program

Oct 14, 2025, 3:02 AM EDT · 1 year ago

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Sep 15, 2025, 6:24 PM EDT · 1 year ago

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

2025-09-12T09:20:11.000Z · 1 year ago

Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program

Sep 11, 2025, 9:54 PM EDT · 1 year ago

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Aug 25, 2025, 2:11 PM EDT · 1 year ago

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

Jul 15, 2025, 5:34 PM EDT · 1 year ago

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

May 12, 2025, 5:14 PM EDT · 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 8, 2025, 5:00 PM EDT · 1 year ago

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Stocktwits

thatboytrades Nov 12, 8:04 PM

$MNDR $CMND $APUS $MKZR my brainrot degenerate portfolio of the year…. holding all…. rest on cash

0 replies

Cornlikker Nov 11, 9:31 PM

$APUS WTF? No Green Day’s? Should I average down or dump this???

0 replies

AvAvAvAv Nov 11, 8:37 PM

$APUS This stock does still exists???? Where is the SEC????

0 replies

AvAvAvAv Nov 10, 8:59 PM

$APUS !

0 replies

Baazigar123 Nov 10, 12:53 PM

$APUS BIAF

0 replies

Skipper_Jack Nov 10, 3:24 AM

$APUS

0 replies

NetworkNewsWire Nov 9, 6:41 PM

TechMediaBreaks – $APUS Subsidiary MindWave Enters Joint Venture Agreement to Establish Bermuda Insurance Business https://ibn.fm/LAnEg

0 replies

Rayvio_News_Filter Nov 9, 1:06 PM

$APUS 🤝 Apimeds Pharmaceuticals US, Inc.'s subsidiary MindWave Innovations Inc. USA enters a shareholders' and joint venture agreement with Skalup Capital Pte Ltd to establish a Bermuda insurance and technology business under the Monaco Insurance brand, subject to regulatory approval.

0 replies